The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A pilot study utilizing molecular profiling to find potential targets and select individualized treatments for patients with metastatic breast cancer.
Gayle S. Jameson
No relevant relationships to disclose
Emanuel Petricoin
Employment or Leadership Position - Personalized Cancer Therapy; Theranostics Health
Consultant or Advisory Role - Personalized Cancer Therapy; Theranostics Health
Stock Ownership - Theranostics Health
Jasgit C. Sachdev
No relevant relationships to disclose
Lance A. Liotta
Consultant or Advisory Role - Theranostics Health
Stock Ownership - Theranostics Health
Research Funding - Side Out Foundation
David Loesch
Employment or Leadership Position - Caris Life Sciences
Stephen Patrick Anthony
Consultant or Advisory Role - Caris Life Sciences
Honoraria - Caris Life Sciences
Manpreet Chadha
No relevant relationships to disclose
Mariaelena Pierobon
Stock Ownership - Theranostics Health
Research Funding - The Side-Out Foundation
Alex Reeder
No relevant relationships to disclose
Monica Fulk
No relevant relationships to disclose
Linda Vocila
No relevant relationships to disclose
Nina Cantafio
Consultant or Advisory Role - Caris Life Sciences; TD2
Bryant Dunetz
Employment or Leadership Position - The Side-Out Foundation (B,U)
Consultant or Advisory Role - The Side-Out Foundation (B,U)
Research Funding - The Side-Out Foundation
Nicholas J. Robert
Research Funding - The Side-Out Foundation